Abstract OT1-12-02: Preliminary report of the PRECISION Trial (Profiling Early Breast Cancer for Radiotherapy Omission): A Phase II Study of Breast-Conserving Surgery Without Adjuvant Radiotherapy for Favorable-Risk Breast Cancer
Lior Z. Braunstein(Memorial Sloan Kettering Cancer Center), Jennifer R. Bellon(Brigham and Women's Hospital), R. Shiloh(Brigham and Women's Hospital), David E. Wazer(Brown University), Atif J. Khan(Memorial Sloan Kettering Cancer Center), Simon N. Powell(Memorial Sloan Kettering Cancer Center), Rachel Jimenez(Mass General Brigham), Deborah Dillon(Harvard University), Paul J. Catalano(Computational Physics (United States)), Eric P. Winer(University of Vermont), Rinaa S. Punglia(Dana-Farber Cancer Institute), Tari A. King(Brigham and Women's Hospital), Oren Cahlon, Elizabeth Buckley, Mahmoud El‐Tamer(Memorial Sloan Kettering Cancer Center), Yu‐Hui Chen(Dana-Farber Cancer Institute), Carmen A. Perez, Julia S. Wong(Brigham and Women's Hospital), Jean L. Wright(University of North Carolina at Chapel Hill)
Cited by 15
Related Papers
Tumour exosome integrins determine organotropic metastasis
|Nature|2015|5.2k
Chemohormonal Therapy in Metastatic Hormone-Sensitive Prostate Cancer
|New England Journal of Medicine|2015|2.8k
Bevacizumab in Combination With Oxaliplatin, Fluorouracil, and Leucovorin (FOLFOX4) for Previously Treated Metastatic Colorectal Cancer: Results From the Eastern Cooperative Oncology Group Study E3200
|Journal of Clinical Oncology|2007|2.3k
3rd ESO–ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 3)
|Annals of Oncology|2016|2.1k